Last updated on January 2020

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

Brief description of study

The purpose of the study is to test the effectiveness (how well the drug works), safety, and tolerability of the investigational drug called NKTR-214, when combined with nivolumab versus nivolumab given alone in participants with previously untreated melanoma skin cancer that is either unable to be surgically removed or has spread

Clinical Study Identifier: NCT03635983

Find a site near you

Start Over

Hospital Clinico Univ. de Santiago-CHUS

Santiago Compostela, Spain
  Connect »